NovaBay Pharmaceuticals (NYSE:NBY) announced today that it entered into a securities purchase agreement worth proceeds of approximately $15 million.
Emeryville, California-based NovaBay’s agreement with certain institutional investors has occurred in connection with a private placement of 15,000 shares of a newly created Series B non-voting convertible preferred stock.
Get the full story at our sister site, Drug Delivery Business News.